Crc November 2025

crc@lists.oulu.fi

15 participants
56 discussions

Opportunity for organoid imaging on-site demo
by Veli-Pekka Ronkainen 05 Nov '25

05 Nov '25

Dear all, Triolab and Leica are offering the BCO Light Microscopy Core Facility an opportunity to host an on-site demo for Leica Viventis Deep Light Sheet Microscope, designed for organoid imaging. They will arrange a webinar introducing the system, and if you are interested and have suitable samples to scan, please let me know by November 11. This will help us plan the on-site demo in Oulu during week 49 (December 1-5). APPLICATION WEBINAR Monday, 10.11.2025 at 13:00-14:15, Helsinki time zone by Dr. Andreas Fulterer, Advanced Workflow Specialist, Leica-Microsystems Registrations: www.triolab.fi/leica-demo<http://www.triolab.fi/leica-demo> Best regards, Veli-Pekka Ronkainen BCO LM Core Facility

1 0

GMO/GMM
by Antti Haapalainen 05 Nov '25

05 Nov '25

Hei, BMTK puolella on tällä viikolla GMO/GMM tarkastuksia. Tämän takia ajattelin muistutella teitä tästä aiheesta. Liitteenä GMO lomakkeita, joilla voi pitää omaa kirjanpitoa GMO:sta. Muutama muistettava asia: * Jokainen työntekijä/tutkija on vastuussa siitä, että tuottamansa GMO on kirjattu, ja tämän tekee työntekijä/tutkija itse. * "mikro-organismilla (MO) tarkoitetaan mikrobiologista solu- tai muuta rakennetta, joka pystyy lisääntymään tai siirtämään perintöainesta, mukaan luettuina virukset, viroidit sekä eläin- ja kasvisoluviljelmät sekä ihmissolu- ja kudosviljelmät" (ote geenitekniikkalaista). * "muuntogeenisellä mikro-organismilla (GMO) tarkoitetaan mikro-organismia, jonka perintöainesta on muunnettu tavalla, joka ei toteudu luonnossa pariutumisen tuloksena tai luonnollisena yhdistelmänä" (ote geenitekniikkalaista). * Eli esim. plasmidi-DNA TE-puskurissa ei ole GMO. * Raportoitavia GMO:ita ovat puolestaan mm. kompetentit solut ja jatkuvat solulinjat vaikkakin ne on tilattu/ostettu firmoista. Nämä sen takia, koska kyseessä on geneettisesti muunneltu solu, joka on meillä/teillä säilytyksessä. * Mahdolliset päivitykset GMO kirjanpitoon tulisi tehdä välittömästi työn edetessä. Hi, FBMM is having GMO/GMM inspections this week. That's why I thought I'd remind you about this topic. Attached are GMO forms for reporting GMOs. A few things to remember: · Every employee/researcher is responsible for the GMO that he/she has produced, and the employee/researcher himself/herself do this. · "microorganism" (MO) means a microbiological cell or other structure capable of replicating or transmitting genetic material, including viruses, viroids, plant and animal cultures, human cell and tissue cultures "(extract from the law concerning genetic engineering law). · "genetically modified micro-organism (GMO)" means a micro-organism whose genetic material has been modified in a way that does not occur naturally as a result of mating or a natural combination "(extract from the law concerning genetic engineering). · So, for example, plasmid DNA in TE buffer is not a GMO. · Reported GMOs are, for example, competent cells and continuous cell lines although they have been ordered/purchased from companies. This is because it is a genetically modified and we have stored those. · Please update you GMO files whenever a new GMO is produced and stored. Terv. Antti

1 1

Ilmoittautuminen ensiapukurssille (EA1) on auki / (Registration for the first aid course (EA1) is open)
by Antti Haapalainen 04 Nov '25

04 Nov '25

Tiedoksi / FYI Ilmoittautuminen ensiapukurssille (EA1) on auki: https://patio.oulu.fi/fi/uutiset/ilmoittautuminen-ensiapukurssille-ea1-auki… Registration for the first aid course (EA1) is open. The course is in Finnish. Courses in English will be announced separately. Terv. Antti

1 0

03 Nov '25

Dear all, Welcome to the FibroHealth Symposium, 19.11.2025, Technopolis Peltola, Oulu, and online! Once again, Oulu will host top-notch scientific presentations at the FibroHealth Symposium, featuring outstanding speakers, posters, and sponsors, culminating with a symposium dinner to close the event. Book your seat now! When: 19.11.2025 Location: Technopolis Peltola, Yrttipellontie 1, 90230, Oulu, Finland, and online Registration: https://link.webropolsurveys.com/S/B55ADD18CE61F7D5 NOTE: Registration for the dinner ends on November 4, but you can still register for the symposium until November 17. [cid:9551ed9a-3218-4b6f-8182-f1fbad563f9d] Programme 08:30-08:55 Registration and coffee (Auditorium Yrttipellontie 1) 08:55-09:00 Welcome (organizers) New Frontiers in Metabolic Research and Patient Perspectives 09:00-09:30 DNA methylation studies on human aging and cardiovascular health by Associate Professor (Docent), Sara Hägg, Karolinska Institutet, Sweden 09:30-10:00 Bone Marrow Adipose Tissue Metabolism as Key Regulator of Osteoarthritis Bone Biology by Dr. Jeroen Geurts, Lausanne University Hospital, Switzerland 10:00-10:40 Coffee & posters, sponsors' stands 10:40-11:00 GLP-1 – An Incretin from Bench to Bedside: Transforming Obesity Treatment by PhD. Ghulam Raza, University of Oulu 11:00-11:20 Distinct mitochondrial responses upon bariatric surgery and calorie limitation by Postdoctoral Research Fellow, Birgitta van der Kolk, University of Helsinki 11:20-11:40 Emerging concepts on the role of brown fat in shaping systemic metabolism by Docent, Mueez U-Din, University of Turku 11:40-12:00 Patient story by Jenny Hurtola 12:00-13:15 Lunch at own cost in Lunch Restaurant Myrsky & Annual autumn meetings of FASO, FCB, and FBS (meeting rooms) Integration of Cell and Bone Biology in the Obesity Research and Drug Development 13:15-13:35 3D white adipocyte cell culture models by PhD. Juulia Lautaoja-Kivipelto, University of Oulu 13:35-13:55 Extracellular vesicles from adipose tissue and their role in adipose-liver communication in MASLD by PhD. Johanna Matilainen, University of Helsinki 13:55-14:15 Bone marrow fat and its effect on bone cells by PhD, Adjunct professor (docent), Kaisa Ivaska, University of Turku 14:15-14:25 Sponsor speech by BioGenium Microsystems 14:25-15:15 Coffee & posters, sponsors' stands Next-Gen Science: Young Researchers Shaping the Future 15:15-15:35 Remodeling the Adipose Vasculature: How Obesity Impairs Capillary Networks by PhD., Docent, Sinem Karaman, University of Helsinki 15:35-15:50 Abstract talk 1: USP10 Regulates Adipocyte Differentiation: Implications for Obesity and Hypoxia-Related Pathways, by PhD Kateryna Kubaichuk 15:50-16:05 Abstract talk 2: Uterine fibrillar collagen accumulation varies throughout the estrous cycle and provides a scaffold for label-free, 3D uterine gland visualization via the SHG-Casting method, by PhD Audrey Savolainen 16:05-16:20 Abstract talk 3: Lower blood cell mitochondrial DNA amount associates with higher all-cause mortality and aging: a 30-year prospective epidemiological study, by MD Attila Sebe 16:20-16:35 FASO doctoral thesis award presentation 2024 16:35-16:40 Final conclusions (organizers) 19:00- Conference dinner at restaurant Veranta and the Young Investigator Prize The FibroHealth Symposium will conclude with a conference dinner at Veranta restaurant. Veranta offers an elegant setting for dinner at the heart of Oulu's city center, located on the third floor of the Sokos Hotel Arina. Note: the registration for the dinner ends on 4 November! Address: Pakkahuoneenkatu 16, 90100 Oulu Organizers and Sponsors The symposium is organized in collaboration by the University of Oulu Fibrobesity program, the Finnish Association for the Study of Obesity (FASO), the Finnish Society for Cell Biologists, and the Finnish Bone Society (FBS). The symposium is sponsored by AH Diagnostic, Berner, BioGenium Microsystems, BioNordika, Nordic Biosite, Triolab, and Vinglab. Come and meet the sponsors during coffee breaks! Welcome to participate! On behalf of the Organizing Committee, Essi Erkkilä --------------------------------------------------------------------------------------- Essi Erkkilä Coordinator, Profi6 Fibrobesity Research Unit of Biomedicine and Internal Medicine (Room S5 224 at the University Hospital) Faculty of Medicine University of Oulu tel. +358 50 521 5852 LinkedIn: FibroHealth Oulu<https://fi.linkedin.com/company/fibrohealth-oulu> <https://fi.linkedin.com/company/fibrohealth-oulu> FibroHealth - Combatting Fibrosis in Chronic Diseases | University of Oulu<https://www.oulu.fi/en/fibrohealth-combatting-fibrosis-chronic-diseases> [cid:6188b32a-15ce-41e3-94cf-8d59b45b145a]

1 0

Call for MRC Oulu research funding 2026 / MRC Oulun tutkimusrahoitushaku 2026
by Riipinen Katja 03 Nov '25

03 Nov '25

Call for MRC Oulu research funding applications 2026 Deadline for applications is 16th November 2025 Medical Research Center Oulu (MRC Oulu, https://oys.fi/mrc-oulu/) is a strategic research organization of the Wellbeing services county of North Ostrobothnia and the University of Oulu. MRC Oulu offers a multidisciplinary research environment for clinical, translational and health care socioeconomic research, and promotes high-level clinical research and internationalization of the research in the field of medical sciences. Call for research funding 2026 MRC Oulu announces a call for research funding for 2026 with a total call allocation of 100 000 EUR. Several smaller grants will be awarded, primarily for 12-month 10% part-time work or for 1-month 100% work. The funding is aimed at MRC Oulu researchers, and it is intended for personal salary expenses for a post-doctoral researcher for 2026 (including all indirect employee costs) or for acquisition of services, equipment and supplies for research use with a maximum of 10 000 EUR. The salary will be based on University's levels (OV04 - OV06) depending on the merits of the applicant. If funding will be used for salary expenses, the researcher will be employed at the University of Oulu according to its employment policy. Regarding procurement, the general procurement guidelines of the University of Oulu must be followed. Who can apply? The applicant must be a researcher of MRC Oulu (i.e. listed as a group leader or a researcher in MRC Oulu documents) with a doctoral degree who is in the early stages of a group leader position or who is just establishing their own research group. Docents can apply, but professor level applicants will not be considered. Either personal salary or project funding (acquisition of services, equipment and supplies) can be applied, not both. How to apply? Combine all the required parts of the application (1*4) in the order 1*4 below and submit as a single PDF file. Use the headings provided. Name the file with the applicant's lastname_firstname.pdf. Required parts of the application: 1) Cover letter (max. 1 page). Informal letter of application, also including the following information: * the name of the applicant and contact information * the name of the MRC Oulu research group * the applied funding (personal salary vs. project funding) 2) Summary of the research plan (max. 2 pages, font size 10, spacing 1): * title of the research project * background and objectives * methods and implementation * research funding plan (justify the funding to be applied for) * references (not counted in the 2 pages of the research plan) 3) CV (max. 2 pages). The CV must follow the Research Council of Finland's CV template (https://www.aka.fi/en/research-funding/apply-for-funding/how-to-apply-for-f…) 4) List of publications. Must follow the Research Council of Finland's template https://www.aka.fi/en/research-funding/apply-for-funding/how-to-apply-for-f… Submit the application via email to katja.riipinen(a)pohde.fi<mailto:katja.riipinen@pohde.fi> by 16th November 2025 at the latest. Applications submitted after the deadline will not be processed. Selection procedure The applications will be evaluated by the scientific committee of MRC Oulu and if necessary, an external evaluation panel. Selection will be based on the evaluation and an overall assessment by the governing board of MRC Oulu. The results of the call will be announced in December 2025 and funding will be available to use in 1.1.2026. All applicants will be notified when the selection process is completed. Further information For more information about eligibility and how to apply, contact MRC Oulu coordinator Katja Riipinen, katja.riipinen(a)pohde.fi<mailto:katja.riipinen@pohde.fi>. Yst. terveisin / Best regards, Katja Riipinen -- Katja Riipinen Koordinaattori, FT, TtK Medical Research Center Oulu<https://oys.fi/mrc-oulu/> | MRC Oulu Oulun yliopistollinen sairaala, Oulun yliopisto 08 315 4680, 050 448 4955 katja.riipinen(a)pohde.fi<mailto:katja.riipinen@pohde.fi> [cid:image001.png@01DC4CA6.4C44C650]

1 0

FW: PubMed-tietoisku 5.11.2025
by Antti Haapalainen 03 Nov '25

03 Nov '25

From: Sirpa Grekula <Sirpa.Grekula(a)oulu.fi> Sent: Monday, November 3, 2025 8:37 AM To: LTK <ltk-staff(a)oulu.fi>; 'ltk-students(a)lists.oulu.fi' <ltk-students(a)lists.oulu.fi>; fbmm <fbmm(a)lists.oulu.fi> Subject: PubMed-tietoisku 5.11.2025 Hei! PubMed-tietoisku pidetään ke 5.11.2025 klo 15-16 Zoomissa https://oulu.zoom.us/j/69921534309?pwd=ZSiw1OHbUTHj7aoF9jhPwKpCsuXwvz.1 Tietoiskussa esitellään PubMed:n perushaku, MeSH-asiasanaston (Medical Subject Headings) käyttö ja Advanced-haku sekä kattava PubMed-haku systemaattista kirjallisuuskatsausta varten. Ennakkoilmoittautumista ei tarvita. Katso myös muut kirjaston tulevat tietoiskut<https://www.oulu.fi/fi/yliopisto/kirjasto/kirjaston-palvelut/apua-tiedonhak…> Tervetuloa! Ystävällisin terveisin Sirpa Grekula Informaatikko Lääketieteen kirjasto PL 7550 (Aapistie 7A) 90014 Oulun yliopisto Sirpa.Grekula(a)oulu.fi<mailto:Sirpa.Grekula@oulu.fi> puh. 0294 485147

1 0

2026

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006

2005

2004

Crc November 2025